Antibody CD79a _B lymphocytes JCB117
- Known as:
- Antibody CD79a _B lymphocytes JCB117
- Catalog number:
- AB01042
- Product Quantity:
- 3.0ml
- Category:
- -
- Supplier:
- Other suppliers
- Gene target:
- Antibody CD79a _B lymphocytes JCB117
Ask about this productRelated genes to: Antibody CD79a _B lymphocytes JCB117
- Gene:
- CD79A NIH gene
- Name:
- CD79a molecule
- Previous symbol:
- IGA
- Synonyms:
- MB-1
- Chromosome:
- 19q13.2
- Locus Type:
- gene with protein product
- Date approved:
- 1992-07-31
- Date modifiied:
- 2019-04-23
Related products to: Antibody CD79a _B lymphocytes JCB117
Related articles to: Antibody CD79a _B lymphocytes JCB117
- To confirm the definitive diagnostic method of vitreoretinal lymphoma by vitrectomy under infusion. - Source: PubMed
Publication date: 2026/06/30
Ohe RintaroOyanagi SonokaInamura ErikoKitaoka TakumiKabasawa TakanobuSuzuki KazushiUchiyama NaoyaShida AmiSuzuki ToshinoriTogashi KeitaKaneko Yutaka - Cutaneous B-cell lymphoma is extremely rare in dogs; only few cases have been reported in veterinary literature, and its clinicopathological characteristics, biological behavior, and classification remain incompletely characterized. - Source: PubMed
Publication date: 2026/06/20
Jeong YunhoLee Min-JiChoi SooyoungKim Dae-YongChung Jin-YoungAhn Jin-OkChoi Eun Wha - Although diabetic peripheral neuropathy (DPN) is a serious complication of diabetes, its molecular causes are still unclear. The aim of this study was therefore to further investigate the pathogenesis of diabetes through whole transcriptome sequencing. - Source: PubMed
Publication date: 2026/06/13
Yan QiZhang MingXu Li-JuanMa JingWang JingWang Xian-MinMa Li - Neonatal leukemia is a rare and aggressive hematologic malignancy, accounting for less than 1% of pediatric leukemias. Mixed phenotype acute leukemia (MPAL) is particularly uncommon in this age group and poses significant diagnostic and therapeutic challenges. Hyperleukocytosis and leukostasis are life-threatening complications requiring urgent intervention. - Source: PubMed
Publication date: 2026/05/29
Bustamante-Ordoñez Marina AMacavilca-Toribio Michele AArenas-Vasquez Judith RRoman-Lazarte VictorZavaleta-Corvera CarlosSamanez-Obeso Ángel - To test, under a pre-planned clinical framework, whether simple multiparametric MRI biomarkers show candidate associations with selected molecular alterations in primary central nervous system lymphoma (PCNSL), with a focus on non-invasive enrichment for CD79B status and the MCD-like phenotype of potential relevance to Bruton tyrosine kinase (BTK) inhibitor stratification. - Source: PubMed
Publication date: 2026/05/29
García-Hidalgo ClementeGarcía Kempf Audena MaríaGaldo Galián DavidConsentino Hernández José AntonioCayuela Espí José Vicente